The immunology of corneal xenotransplantation: A review of the literature

Xenotransplantation

Volumn 17, Issue 5, 2010, Pages 338-349

  Hara, Hidetaka ^a   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

cornea; genetically engineered pig; immune response; pig; transplantation; xenotransplantation

Indexed keywords

CELLULAR IMMUNITY; CORNEA TRANSPLANTATION; CORNEAL GRAFT REJECTION; EXPERIMENTAL STUDY; GENETIC ENGINEERING; GENETIC MANIPULATION; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CORNEAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; MODELS, ANIMAL; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 78349272459     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00608.x     Document Type: Review

References (135)

1. Coster DJ, Williams KA,. Donor cornea procurement: some special problems in Asia. Asia Pac J Ophthalmol 1992; 4: 7-12.
2. Michaeli-Cohen A, Lambert AC, Coloma F, Rootman DS,. Two cases of a penetrating keratoplasty with tissue from a donor who had undergone LASIK surgery. Cornea 2002; 21: 111-113.
3. Mifflin M, Kim M,. Penetrating keratoplasty using tissue from a donor with previous LASIK surgery. Cornea 2002; 21: 537-538. author reply 538-539.
4. Makgotloe AM, Carmichael TR,. Plummeting corneal donations at the Gauteng Cornea and Eye Bank. S Afr Med J 2009; 99: 797.
5. Lass JH, Gal RL, Dontchev M, et al. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology 2008; 115: 627-632. e628.
6. Rehany U, Balut G, Lefler E, Rumelt S,. The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. Cornea 2004; 23: 649-654.
7. Ohno K, Mitooka K, Nelson LR, Hodge DO, Bourne WM,. Keratocyte activation and apoptosis in transplanted human corneas in a xenograft model. Invest Ophthalmol Vis Sci 2002; 43: 1025-1031. (Pubitemid 34258270)
8. Ohno K, Nelson LR, Mitooka K, Bourne WM,. Transplantation of cryopreserved human corneas in a xenograft model. Cryobiology 2002; 44: 142-149.
9. Auchincloss H Jr,. Xenogeneic transplantation. A review. Transplantation 1988; 46: 1-20.
10. Zhang Z, Bedard E, Luo Y, et al. Animal models in xenotransplantation. Expert Opin Investig Drugs 2000; 9: 2051-2068.
11. Kelley CG, Yamaguchi T, Santana E, Kaufman HE,. A primate model of human corneal transplantation. Invest Ophthalmol Vis Sci 1984; 25: 1061-1064.
12. Yamagami S, Usui T, Amano S, Ebihara N,. Bone marrow-derived cells in mouse and human cornea. Cornea 2005; 24: S71-S74.
13. Ross JR, Howell DN, Sanfilippo FP,. Characteristics of corneal xenograft rejection in a discordant species combination. Invest Ophthalmol Vis Sci 1993; 34: 2469-2476.
14. Ross JR, Sanfilippo FP, Howell DN,. Histopathologic features of rejecting orthotopic corneal xenografts. Curr Eye Res 1994; 13: 725-730.
15. Larkin DF, Takano T, Standfield SD, Williams KA,. Experimental orthotopic corneal xenotransplantation in the rat. Mechanisms of graft rejection. Transplantation 1995; 60: 491-497.
16. Tanaka K, Yamada J, Streilein JW,. Xenoreactive CD4 + T cells and acute rejection of orthotopic guinea pig corneas in mice. Invest Ophthalmol Vis Sci 2000; 41: 1827-1832.
17. Oh JY, Kim MK, Ko JH, et al. Acute cell-mediated rejection in orthotopic pig-to-mouse corneal xenotransplantation. Xenotransplantation 2009; 16: 74-82.
18. Yamagami S, Isobe M, Yamagami H, Hori J, Tsuru T,. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. Transplantation 1997; 64: 42-48.
19. Insler MS, Lopez JG,. Heterologous transplantation versus enhancement of human corneal endothelium. Cornea 1991; 10: 136-148.
20. Li C, Xu JT, Kong FS, Li JL,. Experimental studies on penetrating heterokeratoplasty with human corneal grafts in monkey eyes. Cornea 1992; 11: 66-72.
21. Rose AG, Cooper DK, Human PA, Reichenspurner H, Reichart B,. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991; 10: 223-234.
22. Williams KA, Lowe M, Bartlett C, Kelly TL, Coster DJ,. Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation 2008; 86: 1720-1724.
23. Rahman I, Huang MC, Carley F, Hillarby MC, Vasileiadis GT, Tullo A,. The influence of donor and recipient factors in allograft rejection of the human cornea. Eye (Lond) 2010; 24: 334-339.
24. Pan Z, Sun C, Jie Y, Wang N, Wang L,. WZS-pig is a potential donor alternative in corneal xenotransplantation. Xenotransplantation 2007; 14: 603-611.
25. Lee HI, Kim MK, Oh JY, et al. Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation. Xenotransplantation 2007; 14: 612-618.
26. Banerjee S, Dick AD,. Recent developments in the pharmacological treatment and prevention of corneal graft rejection. Expert Opin Investig Drugs 2003; 12: 29-37.
27. Takano T, Williams KA,. Mechanism of corneal endothelial destruction in rejecting rat corneal allografts and xenografts: a role for CD4 + cells. Transplant Proc 1995; 27: 260-261.
28. Shimmura S, Tsubota K,. Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol 2006; 17: 349-355.
29. Muraine M, Toubeau D, Gueudry J, Brasseur G,. Impact of new lamellar techniques of keratoplasty on eye bank activity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 32-38.
30. Werblin TP, Kaufman HE,. Epikeratophakia: the feasibility of xenografts. Cornea 1982; 1: 53-56.
31. Oh JY, Kim MK, Ko JH, et al. Histological differences in full-thickness vs. lamellar corneal pig-to-rabbit xenotransplantation. Vet Ophthalmol 2009; 12: 78-82.
32. Haq M,. Fish cornea for grafting. Br Med J 1972; 2: 712-713.
33. Von Hippel A,. Eine neue Methode der Hornhauttransplantation. Graefes Arch Clin Exp Ophthalmol 1888; 34: 108-130.
34. Tavandzi U, Prochazka R, Usvald D, et al. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment. Transplantation 2007; 83: 1401-1403.
35. Faber C, Wang M, Scherfig E, et al. Orthotopic porcine corneal xenotransplantation using a human graft. Acta Ophthalmol 2009; 87: 917-919.
36. Wood CA,. Historical Review of Corneal Transplantation. Chicago: Cleveland press, 1911.
37. Kissam R,. Ceratoplastice in man. NY J Med Coll Sci 1844; 2: 281-282.
38. Power H,. On transplantation of cornea. IV International Congress of Ophthalmology. 1872: 4. (London).
39. Johnson W,. On four cases of cornea grafting. Br Med J 1886; 2: 1209-1210.
40. May CH,. Transplantation of a rabbit's eye into the human orbit. Archives Ophthal 1887; 16: 47-53.
41. Soomsawasdi B, Romayanonda N, Bhadrakom S,. Hetero-keratoplasy using gibbon donor corneae. Trans Asia Pacific Acad Ophthalmol 1964; 2: 251-261.
42. Durrani KM, Kirmani TH, Hassan MM, Rizvi SM, Tanner JC, Vandeput JJ,. Penetrating keratoplasty with purified bovine collagen: report of a coordinated trial on fifteen human cases. Ann Ophthalmol 1974; 6: 639-646.
43. Zirm E,. Eine erfolgreiche totale keratoplastik (A successful total keratoplasty). Graefe Archiv für Ophthalmol 1906; 64: 580-595.
44. Fanta H,. Eduard Zirm (1863-1944). Klin Monatsbl Augenheilkd 1986; 189: 64-66.
45. Zirm EK,. Eine erfolgreiche totale Keratoplastik (A successful total keratoplasty). 1906. Refract Corneal Surg 1989; 5: 258-261.
46. Niederkorn JY,. The immune privilege of corneal allografts. Transplantation 1999; 67: 1503-1508.
47. Streilein JW,. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879-889.
48. Niederkorn JY,. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74: 167-171.
49. Chong EM, Dana MR,. Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol 2008; 28: 209-222.
50. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA,. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
51. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA,. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396-402.
52. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997; 64: 1107-1111.
53. Hori J, Wang M, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 2006; 177: 5928-5935.
54. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR,. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol 2007; 179: 3672-3679.
55. Keir ME, Butte MJ, Freeman GJ, Sharpe AH,. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704.
56. Sugita S, Usui Y, Horie S, et al. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1 + T helper 1 cells by a contact-dependent mechanism. Invest Ophthalmol Vis Sci 2009; 50: 263-272.
57. Yang W, Li H, Chen PW, et al. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation. Invest Ophthalmol Vis Sci 2009; 50: 273-280.
58. Tsuyuki S, Kono M, Bloom ET,. Cloning and potential utility of porcine Fas ligand: overexpression in porcine endothelial cells protects them from attack by human cytolytic cells. Xenotransplantation 2002; 9: 410-421.
59. Jeon DH, Oh K, Oh BC, et al. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation. Xenotransplantation 2007; 14: 236-242.
60. Streilein JW, Toews GB, Bergstresser PR,. Corneal allografts fail to express Ia antigens. Nature 1979; 282: 326-327.
61. Gillette TE, Chandler JW, Greiner JV,. Langerhans cells of the ocular surface. Ophthalmology 1982; 89: 700-711.
62. Rodrigues MM, Rowden G, Hackett J, Bakos I,. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21: 759-765.
63. Bergstresser PR, Fletcher CR, Streilein JW,. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 1980; 74: 77-80.
64. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS,. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143-173.
65. Jager MJ, Bradley D, Streilein JW,. Immunosuppressive properties of cultured human cornea and ciliary body in normal and pathological conditions. Transpl Immunol 1995; 3: 135-142.
66. Kawashima H, Prasad SA, Gregerson DS,. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994; 153: 1982-1989.
67. Goslings WR, Prodeus AP, Streilein JW, Carroll MC, Jager MJ, Taylor AW,. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci 1998; 39: 989-995.
68. Coster DJ, Williams KA,. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 2005; 140: 1112-1122.
69. Niederkorn JY,. Immune mechanisms of corneal allograft rejection. Curr Eye Res 2007; 32: 1005-1016.
70. Qian Y, Dana MR,. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med 2001; 3: 1-21.
71. Alexandre GP,. From ABO-incompatible human kidney transplantation to xenotransplantation. Xenotransplantation 2004; 11: 233-236.
72. Cooper DK, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238-246.
73. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA,. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755-17762.
74. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559-562.
75. Cooper DK,. Depletion of natural antibodies in non-human primates-a step towards successful discordant xenografting in humans. Clin Transplant 1992; 6: 178-183.
76. Cooper DK, Good AH, Koren E, et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198-205.
77. Oriol R, Ye Y, Koren E, Cooper DK,. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-1442.
78. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008; 21: 1163-1174.
79. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414.
80. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101: 7335-7340.
81. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
82. Mondino BJ, Ratajczak HV, Goldberg DB, Schanzlin DJ, Brown SI,. Alternate and classical pathway components of complement in the normal cornea. Arch Ophthalmol 1980; 98: 346-349.
83. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ,. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 1993; 34: 3579-3584.
84. Mondino BJ, Sumner H,. Complement inhibitors in normal cornea and aqueous humor. Invest Ophthalmol Vis Sci 1984; 25: 483-486.
85. Chandler JW, Leder R, Kaufman HE, Caldwell JR,. Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor. Invest Ophthalmol 1974; 13: 151-153.
86. Hargrave SL, Mayhew E, Hegde S, Niederkorn J,. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection? Transpl Immunol 2003; 11: 79-89.
87. Hegde S, Mellon JK, Hargrave SL, Niederkorn JY,. Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci 2002; 43: 1012-1018.
88. Mishima S,. Clinical investigations on the corneal endothelium-XXXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol 1982; 93: 1-29.
89. Joyce NC,. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res 2003; 22: 359-389.
90. Singh G, Bohnke M, Draeger J,. Endothelial wound healing in organ-cultured pig corneae after mechanical trauma. Fortschr Ophthalmol 1984; 81: 293-295.
91. Schroeter J, Meltendorf C, Ohrloff C, Rieck P,. Influence of temporary hypothermia on corneal endothelial cell density during organ culture preservation. Graefes Arch Clin Exp Ophthalmol 2008; 246: 369-372.
92. Amano S, Shimomura N, Kaji Y, Ishii K, Yamagami S, Araie M,. Antigenicity of porcine cornea as xenograft. Curr Eye Res 2003; 26: 313-318.
93. Hara H, Ezzelarab M, Rood PP, et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans. Xenotransplantation 2006; 13: 357-365.
94. Bouhours D, Pourcel C, Bouhours JE,. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J 1996; 13: 947-953.
95. Cooper DK,. Xenoantigens and xenoantibodies. Xenotransplantation 1998; 5: 6-17.
96. Zhu A,. Binding of human natural antibodies to nonalphaGal xenoantigens on porcine erythrocytes. Transplantation 2000; 69: 2422-2428. (Pubitemid 30409015)
97. Varki A,. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am J Phys Anthropol 2001; 44 (Suppl. 33): 54-69.
98. Ezzelarab M, Ayares D, Cooper DK,. Carbohydrates in xenotransplantation. Immunol Cell Biol 2005; 83: 396-404.
99. Kim YG, Oh JY, Gil GC, et al. Identification of alpha-Gal and non-Gal epitopes in pig corneal endothelial cells and keratocytes by using mass spectrometry. Curr Eye Res 2009; 34: 877-895.
100. Batchelor JR, Casey TA, Werb A, et al. HLA matching and corneal grafting. Lancet 1976; 1: 551-554.
101. ANONYMOUS. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992; 110: 1392-1403.
102. Fink N, Stark WJ, Maguire MG, et al. Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies. Cesk Oftalmol 1994; 50: 3-12.
103. Inoue K, Tsuru T,. ABO antigen blood-group compatibility and allograft rejection in corneal transplantation. Acta Ophthalmol Scand 1999; 77: 495-499. (Pubitemid 29476362)
104. Hahn AB, Foulks GN, Enger C, et al. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation 1995; 59: 21-27.
105. Borderie VM, Lopez M, Vedie F, Laroche L,. ABO antigen blood-group compatibility in corneal transplantation. Cornea 1997; 16: 1-6.
106. Holan V, Vitova A, Krulova M, et al. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection. Immunol Lett 2005; 100: 211-213.
107. Mcclellan BH, Whitney CR, Newman LP, Allansmith MR,. Immunoglobulins in tears. Am J Ophthalmol 1973; 76: 89-101.
108. Raviola G,. Effects of paracentesis on the blood-aqueous barrier: an electron microscope study on Macaca mulatta using horseradish peroxidase as a tracer. Invest Ophthalmol 1974; 13: 828-858.
109. Yamada J, Streilein JW,. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Invest Ophthalmol Vis Sci 1997; 38: 2833-2843.
110. Tanaka K, Streilein JW,. Immunobiology of xenogeneic cornea grafts in mouse eyes. II. Immunogenicity of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes. Transplantation 2000; 69: 616-623. (Pubitemid 30129598)
111. Tanaka K, Yamada J, Joyce N, Streilein JW,. Immunobiology of xenogeneic cornea grafts in mouse eyes. I. Fate of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes. Transplantation 2000; 69: 610-616. (Pubitemid 30129597)
112. Williams KA, Lowe M, Bartels MC, Kelly TL, Coster DJ,. The Australian Corneal Graft Registry 2007 Report. Adelaide: Flinders University Press, 2007: 69-73.
113. Tanaka K, Sonoda K, Streilein JW,. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells. Invest Ophthalmol Vis Sci 2001; 42: 2878-2884.
114. Higuchi R, Streilein JW,. CD8 + T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4 + T cells. Invest Ophthalmol Vis Sci 2003; 44: 175-182.
115. Pepose JS, Nestor MS, Gardner KM, Foos RY, Pettit TH,. Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch Clin Exp Ophthalmol 1985; 222: 128-133.
116. Larkin DF, Alexander RA, Cree IA,. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye 1997; 11 (Pt 1): 68-74.
117. Pindjakova J, Vitova A, Krulova M, Zajicova A, Filipec M, Holan V,. Corneal rat-to-mouse xenotransplantation and the effects of anti-CD4 or anti-CD8 treatment on cytokine and nitric oxide production. Transpl Int 2005; 18: 854-862.
118. Sedlakova K, Filipec M,. Effect of suturing technique on corneal xenograft survival. Cornea 2007; 26: 1111-1114.
119. Strestikova P, Plskova J, Filipec M, Farghali H,. FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide 2003; 9: 111-117.
120. Hegde S, Beauregard C, Mayhew E, Niederkorn JY,. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation 2005; 79: 23-31.
121. Slegers TP, Torres PF, Broersma L, Van Rooijen N, Van Rij G, Van Der Gaag R,. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. Invest Ophthalmol Vis Sci 2000; 41: 2239-2247.
122. Slegers TP, Van Der Gaag R, Van Rooijen N, Van Rij G, Streilein JW,. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts. Curr Eye Res 2003; 26: 73-79.
123. O'reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 1994; 59: 471-482.
124. Eliceiri BP, Cheresh DA,. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227-1230.
125. Pearce JW, Janardhan KS, Caldwell S, Singh B,. Angiostatin and integrin alphavbeta3 in the feline, bovine, canine, equine, porcine and murine retina and cornea. Vet Ophthalmol 2007; 10: 313-319.
126. Hori J, Streilein JW,. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001; 42: 1820-1828.
127. Sedlakova K, Muckersie E, Robertson M, Filipec M, Forrester JV,. FTY720 in corneal concordant xenotransplantation. Transplantation 2005; 79: 297-303.
128. Brinkmann V,. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 2009; 158: 1173-1182.
129. Cozzi E, White DJ,. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964-966.
130. Loveland BE, Milland J, Kyriakou P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004; 11: 171-183.
131. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 2010; 10: 273-285.
132. Phelps CJ, Ball SF, Vaught TD, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009; 16: 477-485.
133. Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009; 16: 522-534.
134. Petersen B, Ramackers W, Lucas-Hahn A, et al. Production and characterization of pigs transgenic for human hemeoxygenase-I by somatic nuclear transfer. Xenotransplantation 2008; 15: 301.
135. Petersen B, Lucas-Hahn A, Lemme E, et al. Generation and characterization of human hemeoxygenase-1 (hHO-1) transgenic pigs. Xenotransplantation 2009; 16: 373-374.